Consistent with the regulon profile, tumor-reactive T cells exhibited higher expression of pro-inflammatory effector molecules such as IFNG, TNF, and PRF1 (Fig. 3C) and lower expression of genes like LBT, CD27, and CD28. This evidence concerns the gene PRF1 and neoplasm.